» Articles » PMID: 18025128

The Healing Myocardium Sequentially Mobilizes Two Monocyte Subsets with Divergent and Complementary Functions

Overview
Journal J Exp Med
Date 2007 Nov 21
PMID 18025128
Citations 1153
Authors
Affiliations
Soon will be listed here.
Abstract

Healing of myocardial infarction (MI) requires monocytes/macrophages. These mononuclear phagocytes likely degrade released macromolecules and aid in scavenging of dead cardiomyocytes, while mediating aspects of granulation tissue formation and remodeling. The mechanisms that orchestrate such divergent functions remain unknown. In view of the heightened appreciation of the heterogeneity of circulating monocytes, we investigated whether distinct monocyte subsets contribute in specific ways to myocardial ischemic injury in mouse MI. We identify two distinct phases of monocyte participation after MI and propose a model that reconciles the divergent properties of these cells in healing. Infarcted hearts modulate their chemokine expression profile over time, and they sequentially and actively recruit Ly-6C(hi) and -6C(lo) monocytes via CCR2 and CX(3)CR1, respectively. Ly-6C(hi) monocytes dominate early (phase I) and exhibit phagocytic, proteolytic, and inflammatory functions. Ly-6C(lo) monocytes dominate later (phase II), have attenuated inflammatory properties, and express vascular-endothelial growth factor. Consequently, Ly-6C(hi) monocytes digest damaged tissue, whereas Ly-6C(lo) monocytes promote healing via myofibroblast accumulation, angiogenesis, and deposition of collagen. MI in atherosclerotic mice with chronic Ly-6C(hi) monocytosis results in impaired healing, underscoring the need for a balanced and coordinated response. These observations provide novel mechanistic insights into the cellular and molecular events that regulate the response to ischemic injury and identify new therapeutic targets that can influence healing and ventricular remodeling after MI.

Citing Articles

Exploring the role of mitochondrial antiviral signaling protein in cardiac diseases.

Qi Y, Yin J, Xia W, Yang S Front Immunol. 2025; 16:1540774.

PMID: 40040697 PMC: 11876050. DOI: 10.3389/fimmu.2025.1540774.


A Mathematical Exploration of the Effects of Ischemia-Reperfusion Injury After a Myocardial Infarction.

Lafci Buyukkahraman M, Chen H, Chen-Charpentier B, Liao J, Kojouharov H Bioengineering (Basel). 2025; 12(2).

PMID: 40001696 PMC: 11851514. DOI: 10.3390/bioengineering12020177.


Emerging Role of Macrophage-Fibroblast Interactions in Cardiac Homeostasis and Remodeling.

Zhang X, Li Q, Tang T, Cheng X JACC Basic Transl Sci. 2025; 10(1):113-127.

PMID: 39958468 PMC: 11830265. DOI: 10.1016/j.jacbts.2024.06.003.


Intracellular iron accumulation throughout the progression of sepsis influences the phenotype and function of activated macrophages in renal tissue damage.

Hanna M, Akabawy A, Khalifa M, Elbaset M, Imam R, Seddiek H Front Physiol. 2025; 16:1430946.

PMID: 39949667 PMC: 11821637. DOI: 10.3389/fphys.2025.1430946.


Effects of injury size on local and systemic immune cell dynamics in volumetric muscle loss.

Whitaker R, Sung S, Tylek T, Risser G, OBrien E, Chua P NPJ Regen Med. 2025; 10(1):9.

PMID: 39939310 PMC: 11822203. DOI: 10.1038/s41536-025-00397-z.


References
1.
Tsou C, Peters W, Si Y, Slaymaker S, Aslanian A, Weisberg S . Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest. 2007; 117(4):902-9. PMC: 1810572. DOI: 10.1172/JCI29919. View

2.
Pfeffer M, Pfeffer J . Ventricular enlargement and reduced survival after myocardial infarction. Circulation. 1987; 75(5 Pt 2):IV93-7. View

3.
Pfeffer M, Braunwald E . Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990; 81(4):1161-72. DOI: 10.1161/01.cir.81.4.1161. View

4.
Libby P . Inflammation in atherosclerosis. Nature. 2002; 420(6917):868-74. DOI: 10.1038/nature01323. View

5.
Morimoto H, Takahashi M, Izawa A, Ise H, Hongo M, Kolattukudy P . Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ Res. 2006; 99(8):891-9. DOI: 10.1161/01.RES.0000246113.82111.2d. View